The Food and Drug Administration has approved a new treatment for late-stage breast cancer, the agency said.

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

The Food and Drug Administration has approved a drug made by Genentech for treating a rare and severe form of arthritis that affects children, Genentech said.

Procter & Gamble on Tuesday afternoon named a healthcare veteran to its board. Susan Desmond-Hellmann, 53, chancellor of the University of California, San Francisco was named to the board, effective Dec. 13.